Penile Venous Ligation Surgery
Penile venous ligation surgery treats corporeal veno-occlusive dysfunction (CVOD) — also called venous leak — in which inadequate trapping of blood within the corpora cavernosa prevents the achievement or maintenance of erection. The classic operation resects the deep dorsal vein and ligates pathologic drainage pathways. The AUA 2018 guideline does not recommend penile venous surgery for ED (Moderate Recommendation; Grade C), citing inconsistent long-term outcomes — but recent combined open-endovascular approaches and standalone embolization have renewed interest in highly selected patients.[1][2]
"For men with ED, penile venous surgery is not recommended (Moderate Recommendation; Evidence Level: Grade C)" — venous ligation is unlikely to result in long-term success for the overwhelming majority and delays treatment with more reliable options such as penile prosthesis surgery.[1]
The procedure may have a role in carefully selected young men with primary venous leak, normal arterial inflow, and no significant comorbidities, particularly when combined with modern endovascular embolization. The contemporary direction is embolization-first or combined ligation + embolization, not isolated open ligation.[3][4][5]
Pathophysiology and rationale
Normal erection requires arterial inflow, sinusoidal smooth-muscle relaxation, and compression of subtunical venules against the tunica albuginea (the veno-occlusive mechanism). In CVOD, blood drains prematurely through incompetent veins — most commonly the deep dorsal vein, cavernous veins, and crural veins. Surgery aims to eliminate these pathologic drainage pathways.[6][2]
Critical conceptual caveat. Contemporary understanding suggests that CVOD is often an effect rather than a primary cause of ED — secondary to smooth-muscle degeneration, fibrosis, or arterial insufficiency. This partly explains the variable surgical outcomes and the AUA's negative recommendation.[2]
Preoperative diagnosis and patient selection
Diagnosis of venous leak requires hemodynamic confirmation:
| Test | Finding |
|---|---|
| Pharmacologically challenged penile duplex sonography (PC-PDS) | Elevated end-diastolic velocity (EDV > 5 cm/s) in cavernosal arteries with normal peak systolic velocity (PSV > 30 cm/s) |
| Dynamic infusion cavernosometry / cavernosography (DICC) | Maintenance flow rates and identification of leak sites[7][8] |
| CT cavernosography | Anatomic mapping of leak sites — increasingly used contemporary tool[7][8] |
Favorable patient-selection criteria[9][10]:
- Young age, primary (often congenital) venous leak.
- Normal arterial inflow on PC-PDS and SIPA.
- Mild-to-moderate leak on cavernosometry.
- Normal cavernous electromyography (SPACE) — abnormal results predict poor outcomes (68% success normal SPACE vs 8% abnormal).[10]
- No significant atherosclerosis, diabetes, or smoking.
- Smooth-muscle content preserved on biopsy where assessed.
Surgical technique
The classic open procedure[9][11][12]:
| Step | Detail |
|---|---|
| 1. Incision | Infrapubic or inguinoscrotal approach. |
| 2. Resection of the deep dorsal vein | From the coronal sulcus to the pubic arch. Resection has shown slightly better results than simple ligation alone.[12] |
| 3. Ligation of cavernous veins | At the penile hilum. |
| 4. Crural ligation | Banding of the crura proximal to the entrance of the cavernous artery using umbilical tapes (in more extensive procedures, e.g. Cayan 2008). |
| 5. Preservation | Preserve dorsal arteries and dorsal nerves bilaterally. |
Outcomes — high initial response, low durability
Results are highly variable and depend heavily on patient selection, technique, and follow-up duration.
| Series | n | Follow-up | Success | Notes |
|---|---|---|---|---|
| Wespes 1985[6] | 20 | Short-term | 80% improved | Failures had concomitant arterial disease |
| Wespes 1992[12] | 67 | Long-term | ~ 46% potent | 7 relapses from deeper vein leakage; 11 failures from arterial disease |
| Freedman 1993[13] | 46 | > 12 mo | 24% sustained potency | 74% initial improvement but high relapse; distal leak (43%) > proximal leak (16%) |
| Hwang 1994[14] | 35 | 27.5 mo (mean) | 40% sustained | 93% initial success; crural-vein leakage major cause of recurrence |
| Stief 1994[10] | 77 | 21 mo (mean) | 40% full erections | Normal SPACE predicted success (68% vs 8%) |
| Kim & McVary 1995[15] | 15 | 29 mo (mean) | 60% potent | Shorter ED duration predicted success; 40% penile contracture |
| Cayan 2008[9] | 26 | ≥ 12 mo | 42% complete + 31% partial | IIEF 6.7 → 16.3; 88% satisfaction with or without PDE5i |
| Allaire 2021[3] (combined ligation + embolization) | 45 | 14 mo | 73–82% secondary success | Combined open + endovascular |
| Allaire 2025[4] (combined) | 171 | 23 mo | 80.7% improvement | Largest contemporary series; 14% required re-operation |
Pattern. Initial success rates 60–90% but long-term sustained potency drops to ~ 24–50% in most older series.[13][14][12] Combined open-endovascular approaches (Allaire 2021/2025) report higher sustained success (73–82%), but lack RCT data.[3][4]
Complications
| Complication | Rate | Notes |
|---|---|---|
| Penile shortening | 20–43% | Substantial — counsel explicitly[13][14] |
| Penile hypoesthesia / glans numbness | 4–20% | [13][14] |
| Penile deviation / curvature | Reported in some series | [14] |
| Wound infection | Rare | [14] |
| Recurrence of ED | Common long-term | Driven by collateral venous drainage or incomplete elimination of leak sites — especially crural veins.[14][13] |
| Penile contracture | 40% (Kim & McVary 1995) | [15] |
Emerging — venous-leak embolization
Endovascular embolization of venous-leak sites has emerged as a less invasive alternative or adjunct:
- Hoppe 2026 multicenter registry n = 175: 59.4% achieved ≥ 4-point IIEF improvement at midterm (~ 9 mo); 10.2% venous-leak recurrence; non-target pulmonary embolism 1.7% (the dominant safety concern).[16]
- Allaire 2021 / 2025 combined open ligation + embolization in a single procedure (n = 45 / n = 171): 73–82% secondary success.[3][4]
- PiVET-ED trial — ongoing prospective, randomized, sham-controlled study evaluating pelvic-vein embolization for venogenic ED. May provide higher-quality evidence.[17]
Guideline position
| Body | Position |
|---|---|
| AUA 2018[1] | Not recommended (Moderate Recommendation; Grade C) — unlikely to result in long-term success; delays prosthesis treatment |
| EAU / ESSM | No formal endorsement; embolization investigational |
When to refer / when not to operate
- Select cautiously: young man, primary / congenital venous leak, normal arterial inflow on PC-PDS and SIPA, normal SPACE, mild-to-moderate leak on DICC, no atherosclerosis, no diabetes, non-smoker, smooth-muscle content preserved, and the patient is fully informed about the AUA non-recommendation and high recurrence rate.
- Do not operate: arterial-component ED, atherosclerosis, abnormal SPACE, smoking, diabetes, prior failed medical therapy where a penile prosthesis would be a more reliable next step.
- Modern direction: embolization-first or combined ligation + embolization at experienced centers, not isolated open ligation.[3][4][16]
Postoperative management
- Activity restriction. Avoid intercourse, masturbation, cycling, and strenuous exercise for 4–6 weeks.
- Postoperative duplex Doppler at ~ 6 weeks to confirm absence of recurrent leak.
- PDE5i bridging is commonly used postoperatively to support tumescence-driven flow.
- PRO assessment. IIEF / IIEF-5 at baseline, 3 mo, 6 mo, 12 mo, with annual follow-up given known late attrition.
- Counseling. Patients must be told preoperatively about the 20–43% penile shortening rate and the high long-term recurrence rate; document the AUA 2018 non-recommendation.
See Also
- Erectile Dysfunction Atlas (04j ED database)
- Erectile Dysfunction (clinical condition)
- Penile Arterial Revascularization
- Penile Implants — the more reliable definitive treatment per AUA 2018
References
1. Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633–641. doi:10.1016/j.juro.2018.05.004
2. Hsieh CH, Hsu GL, Chang SJ, et al. Surgical niche for the treatment of erectile dysfunction. Int J Urol. 2020;27(2):117–133. doi:10.1111/iju.14157
3. Allaire E, Sussman H, Zugail AS, et al. Erectile dysfunction resistant to medical treatment caused by cavernovenous leakage: an innovative surgical approach combining pre-operative work-up, embolisation, and open surgery. Eur J Vasc Endovasc Surg. 2021;61(3):510–517. doi:10.1016/j.ejvs.2020.08.048
4. Allaire E, Hauet P, Floresco J, et al. Ligation and embolization in one procedure for caverno-venous leakage in 171 patients with drug-resistant erectile dysfunction. Ann Vasc Surg. 2025;S0890-5096(25)00578-3. doi:10.1016/j.avsg.2025.08.025
5. Sasso F, Gulino G, Weir J, Viggiano AM, Alcini E. Patient selection criteria in the surgical treatment of veno-occlusive dysfunction. J Urol. 1999;161(4):1145–1147.
6. Wespes E, Schulman CC. Venous leakage: surgical treatment of a curable cause of impotence. J Urol. 1985;133(5):796–798. doi:10.1016/s0022-5347(17)49231-7
7. Aversa A, Sarteschi LM. The role of penile color-duplex ultrasound for the evaluation of erectile dysfunction. J Sex Med. 2007;4(5):1437–1447. (PC-PDS reference)
8. Hsu GL, Hsieh CH, Wen HS, et al. Penile venous anatomy: an additional description and its clinical implication. J Androl. 2003;24(6):921–927. (CT cavernosography reference)
9. Cayan S. Primary penile venous leakage surgery with crural ligation in men with erectile dysfunction. J Urol. 2008;180(3):1056–1059. doi:10.1016/j.juro.2008.05.024
10. Stief CG, Djamilian M, Truss MC, et al. Prognostic factors for the postoperative outcome of penile venous surgery for venogenic erectile dysfunction. J Urol. 1994;151(4):880–883. doi:10.1016/s0022-5347(17)35112-1
11. Sasso F, Gulino G, Weir J, Viggiano AM, Alcini E. Patient selection criteria in the surgical treatment of veno-occlusive dysfunction. J Urol. 1999;161(4):1145–1147.
12. Wespes E, Delcour C, Preserowitz L, et al. Impotence due to corporeal veno-occlusive dysfunction: long-term follow-up of venous surgery. Eur Urol. 1992;21(2):115–119. doi:10.1159/000474815
13. Freedman AL, Costa Neto F, Mehringer CM, Rajfer J. Long-term results of penile vein ligation for impotence from venous leakage. J Urol. 1993;149(5 Pt 2):1301–1303. doi:10.1016/s0022-5347(17)36374-7
14. Hwang TI, Yang CR. Penile vein ligation for venogenic impotence. Eur Urol. 1994;26(1):46–51. doi:10.1159/000475341
15. Kim ED, McVary KT. Long-term results with penile vein ligation for venogenic impotence. J Urol. 1995;153(3 Pt 1):655–658. doi:10.1097/00005392-199503000-00029
16. Hoppe H, Heymann G, Müller D, et al. Midterm outcomes of venous leak embolization in patients with venogenic erectile dysfunction unresponsive to phosphodiesterase-5 inhibitors. Cardiovasc Intervent Radiol. 2026;49(3):556–566. doi:10.1007/s00270-025-04246-w
17. Moriarty HK, Kavnoudias H, Blecher G, et al. PIVET-ED: a prospective, randomised, single-blinded, sham controlled study of pelvic vein embolisation for treatment of erectile dysfunction. Cardiovasc Intervent Radiol. 2022;45(2):155–161. doi:10.1007/s00270-021-03021-x